Abstract

Simple SummaryMultielectrode array technology allows researchers to record the spontaneous firing activity of cultured neurons over a period of multiple weeks or months. These data can be valuable for understanding how the functional relationships between neurons evolve as they begin to form connections and wire into a functional network. This technology has been adopted by researchers using stem cells to produce human neurons in culture to study neurodevelopmental disorders. However, the dizzying complexity and scale of the data generated have posed some challenges with the analysis and interpretation of experimental results. Here, we first provide historical context as to why multielectrode array platforms were originally developed, and use this perspective to explore some of the challenges currently facing the field. We then highlight new analysis methods, provide some guidance for improving the analysis of multielectrode array data, and discuss standardizing how these findings are communicated in scientific publications.In vitro multielectrode array (MEA) systems are increasingly used as higher-throughput platforms for functional phenotyping studies of neurons in induced pluripotent stem cell (iPSC) disease models. While MEA systems generate large amounts of spatiotemporal activity data from networks of iPSC-derived neurons, the downstream analysis and interpretation of such high-dimensional data often pose a significant challenge to researchers. In this review, we examine how MEA technology is currently deployed in iPSC modeling studies of neurodevelopmental disorders. We first highlight the strengths of in vitro MEA technology by reviewing the history of its development and the original scientific questions MEAs were intended to answer. Methods of generating patient iPSC-derived neurons and astrocytes for MEA co-cultures are summarized. We then discuss challenges associated with MEA data analysis in a disease modeling context, and present novel computational methods used to better interpret network phenotyping data. We end by suggesting best practices for presenting MEA data in research publications, and propose that the creation of a public MEA data repository to enable collaborative data sharing would be of great benefit to the iPSC disease modeling community.

Highlights

  • Induced pluripotent stem cell technology has afforded many benefits for the modeling and study of human neurodevelopmental disorders

  • With the inclusion of multielectrode array (MEA) phenotyping assays becoming more commonplace in induced pluripotent stem cell (iPSC) disease modeling studies, there is a need for discussion within the field about best practices when it comes to the reporting and publication of MEA phenotyping data

  • We have highlighted some of the current challenges with standardizing MEA experiments within the iPSC disease modeling field and provided some recommendations for working towards this goal

Read more

Summary

Introduction

Induced pluripotent stem cell (iPSC) technology has afforded many benefits for the modeling and study of human neurodevelopmental disorders. Using well-established induction protocols, reprogrammed iPSCs can be differentiated into functional neuronal and glial cell types of interest carrying the same genetic background as the patient they were originally derived from, preserving the complex genetic architecture associated with many neurodevelopmental disorders They can be used as a platform to evaluate the effect of genetic rescue intervention. Researchers are afforded a renewable source of patient-derived neurons and glial cells for study and experimentation, without requiring any invasive biopsy of human CNS tissue These in vitro cultures of iPSC-derived neuronal cells can be utilized in molecular, morphological, and functional phenotyping experiments, as well as for investigating the effect of rescue genetic manipulations and preclinical drugs. We discuss some of the more recent developments applying MEA technology to iPSC disease modeling studies, as well as the challenges that come with the analysis and interpretation of complex multichannel data

Historical Perspectives
Developing Long-Term Culture Methods for Nervous Tissue
Early MEA Technology
Qualitative Descriptions of Network Activity
Quantitative Descriptions of Network Activity
Generating Neurons and Glia for MEA Phenotyping Assays
Neuronal Differentiation Methods for Generating Functional Neurons
Challenges with Current Approaches to MEA Phenotyping
Spike Sorting for Improved Firing Rate Statistics
Standardizing MEA Data Reporting
Conclusions and Recommendations
Considerations for Experimental Design
Considerations for MEA Data Analysis
Considerations for Data Reporting

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.